1. Home
  2. BHVN vs ENVX Comparison

BHVN vs ENVX Comparison

Compare BHVN & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.25

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$6.11

Market Cap

1.6B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
ENVX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
BHVN
ENVX
Price
$11.25
$6.11
Analyst Decision
Buy
Strong Buy
Analyst Count
14
7
Target Price
$27.69
$17.14
AVG Volume (30 Days)
1.9M
5.7M
Earning Date
01-01-0001
04-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
N/A
Revenue
N/A
$23,074,000.00
Revenue This Year
N/A
$36.03
Revenue Next Year
N/A
$102.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
201.86
52 Week Low
$7.48
$5.27
52 Week High
$37.36
$16.49

Technical Indicators

Market Signals
Indicator
BHVN
ENVX
Relative Strength Index (RSI) 45.94 40.86
Support Level $10.75 $5.70
Resistance Level $11.80 $8.73
Average True Range (ATR) 0.63 0.42
MACD -0.05 0.06
Stochastic Oscillator 16.63 34.65

Price Performance

Historical Comparison
BHVN
ENVX

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

Share on Social Networks: